Synta Pharmaceuticals (SNTA) Announces Upcoming Oral Presentations On Hsp90-Inhibitor Drug Conjugate (HDC) Platform
2/18/2014 9:56:40 AM
LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the following HDC oral presentations are scheduled to take place:
Help employers find you! Check out all the jobs and post your resume.
comments powered by